NELFB
Negative elongation factor B
You are using an outdated browser. Please upgrade your browser to improve your experience.
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
interacting protein | 0.99 | ||
histone modification site profile | 0.91 | ||
co-expressed gene | 0.89 | ||
pathway | 0.78 | ||
hub protein | 0.75 | ||
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
- OR - satisfy the following criterion:
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Target has at least one approved drug - AND - satisfies the preceding conditions
Click on a row in the table to change the structure displayed.
Data Source | Name | Explore in Pharos | Explore in Source | ||
---|---|---|---|---|---|
Reactome | Abortive elongation of HIV-1 transcript in the absence of Tat | ||||
Reactome | Disease | ||||
Reactome | Formation of HIV elongation complex in the absence of HIV Tat | ||||
Reactome | Formation of HIV-1 elongation complex containing HIV-1 Tat | ||||
Reactome | Formation of RNA Pol II elongation complex | ||||
Name | Explore in Pharos | Explore in Source | ||
---|---|---|---|---|
Abortive elongation of HIV-1 transcript in the absence of Tat | ||||
Disease | ||||
Formation of HIV elongation complex in the absence of HIV Tat | ||||
Formation of HIV-1 elongation complex containing HIV-1 Tat | ||||
Formation of RNA Pol II elongation complex | ||||
GO Term | Evidence | Assigned by | ||
---|---|---|---|---|
Inferred from Electronic Annotation (IEA) | UniProtKB-KW | |||
GWAS Trait | EFO ID | Study Count | SNP Count | Beta Count | Odds Ratio | Evidence (Mean Rank Score) | Provenance | ||
---|---|---|---|---|---|---|---|---|---|
chronotype measurement | 4 | 2 | 3 | 1.1 | 90.8 | ||||
glomerular filtration rate | 3 | 3 | 4 | 89.1 | |||||
creatinine measurement | 1 | 2 | 2 | 86.1 | |||||
mathematical ability | 4 | 2 | 4 | 85.2 | |||||
reticulocyte measurement | 3 | 1 | 3 | 82.3 | |||||
GWAS Trait | EFO ID | Beta Count | Odds Ratio | Evidence (Mean Rank Score) | Provenance | ||
---|---|---|---|---|---|---|---|
chronotype measurement | 3 | 1.1 | 90.8 | ||||
glomerular filtration rate | 4 | 89.1 | |||||
creatinine measurement | 2 | 86.1 | |||||
mathematical ability | 4 | 85.2 | |||||
reticulocyte measurement | 3 | 82.3 | |||||
Species | Name | Source ID | Gene ID | OMA | EggNOG | Inparanoid | ||
---|---|---|---|---|---|---|---|---|
Chimp | negative elongation factor complex member B | VGNC:13923 | 736409 | |||||
Macaque | negative elongation factor complex member B | 704966 | ||||||
Mouse | MGI:1931035 | 58202 | ||||||
Rat | RGD:1307832 | 311796 | ||||||
Dog | negative elongation factor complex member B | VGNC:43737 | 491230 | |||||
Species | Name | OMA | EggNOG | Inparanoid | ||
---|---|---|---|---|---|---|
Chimp | negative elongation factor complex member B | |||||
Macaque | negative elongation factor complex member B | |||||
Mouse | ||||||
Rat | ||||||
Dog | negative elongation factor complex member B | |||||
PMID | Year | Title |
---|